Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2017

26.04.2017 | Clinical Trial

Abbreviated breast dynamic contrast-enhanced MR imaging for lesion detection and characterization: the experience of an Italian oncologic center

verfasst von: Antonella Petrillo, Roberta Fusco, Mario Sansone, Marilena Cerbone, Salvatore Filice, Annamaria Porto, Maria Rosaria Rubulotta, Massimiliano D’Aiuto, Franca Avino, Maurizio Di Bonito, Gerardo Botti

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

To evaluate the performance of an abbreviated dynamic contrast-enhanced MR imaging (MRI) protocol for breast cancer detection; a comparison with the complete diagnostic protocol has been conducted.

Methods

A retrospective analysis on 508 patients was performed. Abbreviated protocol (AP) included one pre-contrast and the first post-contrast T1-weighted series. Complete protocol (CP) consisted of four post-contrast and one pre-contrast T1-weighted series. Diagnostic performance was assessed for AP and CP. Performance comparison was made using McNemar’s test for sensitivity and specificity and Moskowitz and Pepe’s method as regards negative predictive value (NPV) and positive predictive value (PPV). AP has been realized in two different ways (AP1 and AP2) and they were compared by means of Cohen’s κ.

Results

Both CP and AP revealed 206 of 207 cancers. There were no statistically significant differences between AP and CP diagnostic performance (P > 0.05). NPVs of CP and both versions of AP (99.57 vs. 99.56%, P = 0.39), as well as the specificity (77.08 vs. 75.42%, P = 0.18), were substantially equivalent. Relative predictive value method did not reveal the presence of a statistically significant difference between the PPV of CP and both versions of AP (74.91 vs. 73.57%, P = 0.099). Analysis for single lesion confirmed that both CP and AP had equivalent results: CP and AP revealed 280 of 281 malignancies. NPVs of CP and both AP versions, as well as the specificity (P > 0.05), were substantially equivalent. Relative predictive value method did not reveal the presence of a significant difference between the PPV of CP and both AP versions (70.89 vs. 70.18%, P = 0.25; 70.89 vs. 70.00%, P = 0.13).

Conclusions

Abbreviated approach to breast MRI examination reduces the image acquisition and the reading time associated with MR substantially without influencing the diagnostic accuracy (high sensitivity and NPV >99.5%). AP could translate into cost-savings and could enable a higher number of examinations within the same MR session.
Literatur
2.
Zurück zum Zitat Morrow M, Waters J, Morris E (2011) MRI for breast cancer screening, diagnosis, and treatment. Lancet 378(9805):1804–1811CrossRefPubMed Morrow M, Waters J, Morris E (2011) MRI for breast cancer screening, diagnosis, and treatment. Lancet 378(9805):1804–1811CrossRefPubMed
3.
Zurück zum Zitat Gotzsche PC, Nielsen M (2011) Screening for breast cancer with mammography. Cochrane Database Syst Rev 1:CD001877 Gotzsche PC, Nielsen M (2011) Screening for breast cancer with mammography. Cochrane Database Syst Rev 1:CD001877
4.
Zurück zum Zitat Ferris M, Hall MD (2008) The rise and impending decline of screening mammography. Radiology 247:597–601CrossRef Ferris M, Hall MD (2008) The rise and impending decline of screening mammography. Radiology 247:597–601CrossRef
5.
Zurück zum Zitat Petrillo A, Fusco R, Petrillo M, Triunfo F, Filice S, Vallone P, Setola SV, Rubulotta M, Di Bonito M, Rinaldo M, D’Aiuto M, Brunetti A (2016) Added value of breast MRI for preoperative diagnosis of ductal carcinoma in situ: diagnostic performance on 362 patients. Clin Breast Cancer. doi:10.1016/j.clbc.2016.12.007 PubMed Petrillo A, Fusco R, Petrillo M, Triunfo F, Filice S, Vallone P, Setola SV, Rubulotta M, Di Bonito M, Rinaldo M, D’Aiuto M, Brunetti A (2016) Added value of breast MRI for preoperative diagnosis of ductal carcinoma in situ: diagnostic performance on 362 patients. Clin Breast Cancer. doi:10.​1016/​j.​clbc.​2016.​12.​007 PubMed
6.
Zurück zum Zitat Fusco R, Sansone M, Filice S, Carone G, Amato DM, Sansone C, Petrillo A (2016) Pattern recognition approaches for breast cancer DCE-MRI classification: a systematic review. J Med Biol Eng 36(4):449–459CrossRefPubMedPubMedCentral Fusco R, Sansone M, Filice S, Carone G, Amato DM, Sansone C, Petrillo A (2016) Pattern recognition approaches for breast cancer DCE-MRI classification: a systematic review. J Med Biol Eng 36(4):449–459CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Petrillo A, Fusco R, Filice S, Granata V, Catalano O, Vallone P, Di Bonito M, D’Aiuto M, Rinaldo M, Capasso I, Sansone M (2016) Breast contrast enhanced MR imaging: semi-automatic detection of vascular map and predominant feeding vessel. PLoS ONE 11(8):e0161691CrossRefPubMedPubMedCentral Petrillo A, Fusco R, Filice S, Granata V, Catalano O, Vallone P, Di Bonito M, D’Aiuto M, Rinaldo M, Capasso I, Sansone M (2016) Breast contrast enhanced MR imaging: semi-automatic detection of vascular map and predominant feeding vessel. PLoS ONE 11(8):e0161691CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Fusco R, Sansone M, Filice S, Granata V, Catalano O, Amato DM, Di Bonito M, D’Aiuto M, Capasso I, Rinaldo M, Petrillo A (2015) Integration of DCE-MRI and DW-MRI quantitative parameters for breast lesion classification. Biomed Res Int 2015:237863CrossRefPubMedPubMedCentral Fusco R, Sansone M, Filice S, Granata V, Catalano O, Amato DM, Di Bonito M, D’Aiuto M, Capasso I, Rinaldo M, Petrillo A (2015) Integration of DCE-MRI and DW-MRI quantitative parameters for breast lesion classification. Biomed Res Int 2015:237863CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Fusco R, Sansone M, Filice S, Petrillo A (2016) Breast contrast-enhanced MR imaging: semiautomatic detection of vascular map. Breast Cancer 23(2):266–272CrossRefPubMed Fusco R, Sansone M, Filice S, Petrillo A (2016) Breast contrast-enhanced MR imaging: semiautomatic detection of vascular map. Breast Cancer 23(2):266–272CrossRefPubMed
10.
Zurück zum Zitat Petrillo A, Porto A, Fusco R, Filice S, Vallone P, Rubulotta MR, Fulciniti F, Di Bonito M, D’Aiuto M, Capasso I, Trimboli RM, Sardanelli F (2013) Surgical impact of preoperative breast MRI in women below 40 years of age. Breast Cancer Res Treat 140(3):527–533CrossRefPubMed Petrillo A, Porto A, Fusco R, Filice S, Vallone P, Rubulotta MR, Fulciniti F, Di Bonito M, D’Aiuto M, Capasso I, Trimboli RM, Sardanelli F (2013) Surgical impact of preoperative breast MRI in women below 40 years of age. Breast Cancer Res Treat 140(3):527–533CrossRefPubMed
11.
Zurück zum Zitat Kuhl C, Weigel S, Schrading S, Arand B, Bieling H, König R, Tombach B, Leutner C, Rieber-Brambs A, Nordhoff D, Heindel W, Reiser M, Schild HH (2010) Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol 28(9):1450–1457CrossRefPubMed Kuhl C, Weigel S, Schrading S, Arand B, Bieling H, König R, Tombach B, Leutner C, Rieber-Brambs A, Nordhoff D, Heindel W, Reiser M, Schild HH (2010) Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol 28(9):1450–1457CrossRefPubMed
12.
Zurück zum Zitat Stoutjesdijk MJ, Boetes C, Jager GJ, Beex L, Bult P, Hendriks JHCL, Laheij RJF, Massuger L, van Die LE, Wobbes T, Barentsz JO (2001) Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst 93(14):1095–1102CrossRefPubMed Stoutjesdijk MJ, Boetes C, Jager GJ, Beex L, Bult P, Hendriks JHCL, Laheij RJF, Massuger L, van Die LE, Wobbes T, Barentsz JO (2001) Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst 93(14):1095–1102CrossRefPubMed
13.
Zurück zum Zitat Kim JY, Cho N, Koo HR, Yi A, Kim WH, Lee SH, Chang JM, Han W, Moon HG, Im SA, Noh DY, Moon WK (2013) Unilateral breast cancer: screening of contralateral breast by using preoperative MR imaging reduces incidence of metachronous cancer. Radiology 267(1):57–66CrossRefPubMed Kim JY, Cho N, Koo HR, Yi A, Kim WH, Lee SH, Chang JM, Han W, Moon HG, Im SA, Noh DY, Moon WK (2013) Unilateral breast cancer: screening of contralateral breast by using preoperative MR imaging reduces incidence of metachronous cancer. Radiology 267(1):57–66CrossRefPubMed
14.
Zurück zum Zitat Kuhl CK, Schrading S, Strobel K, Schild HH, Hilgers RD, Bieling HB (2014) Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection—a novel approach to breast cancer screening with MRI. J Clin Oncol 32(22):2304–2310CrossRefPubMed Kuhl CK, Schrading S, Strobel K, Schild HH, Hilgers RD, Bieling HB (2014) Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection—a novel approach to breast cancer screening with MRI. J Clin Oncol 32(22):2304–2310CrossRefPubMed
15.
Zurück zum Zitat Petrillo A, Petrillo M, Fulciniti F, Raso MM, Thomas R, Botti G, Siani A. Primary phyllodes tumor of the axilla: DCE-MRI findings with 1.5T breast-dedicated system and pathological correlation. Breast J. 2011 Sep-Oct;17(5):525-7 Petrillo A, Petrillo M, Fulciniti F, Raso MM, Thomas R, Botti G, Siani A. Primary phyllodes tumor of the axilla: DCE-MRI findings with 1.5T breast-dedicated system and pathological correlation. Breast J. 2011 Sep-Oct;17(5):525-7
16.
Zurück zum Zitat Sardanelli F, Giuseppetti GM, Canavese G, Cataliotti L, Corcione S, Cossu E, Federico M, Marotti L, Martincich L, Panizza P, Podo F, Rosselli Del Turco M, Zuiani C, Alfano C, Bazzocchi M, Belli P, Bianchi S, Cilotti A, Calabrese M, Carbonaro L, Cortesi L, Di Maggio C, Del Maschio A, Esseridou A, Fausto A, Gennaro M, Girometti R, Ienzi R, Luini A, Manoukian S, Morassutt S, Morrone D, Nori J, Orlacchio A, Pane F, Panzarola P, Ponzone R, Simonetti G, Torricelli P, Valeri G (2008) Indications for breast magnetic resonance imaging. Consensus document “Attualità in senologia”, Florence 2007. Radiol Med 113(8):1085–1095CrossRefPubMed Sardanelli F, Giuseppetti GM, Canavese G, Cataliotti L, Corcione S, Cossu E, Federico M, Marotti L, Martincich L, Panizza P, Podo F, Rosselli Del Turco M, Zuiani C, Alfano C, Bazzocchi M, Belli P, Bianchi S, Cilotti A, Calabrese M, Carbonaro L, Cortesi L, Di Maggio C, Del Maschio A, Esseridou A, Fausto A, Gennaro M, Girometti R, Ienzi R, Luini A, Manoukian S, Morassutt S, Morrone D, Nori J, Orlacchio A, Pane F, Panzarola P, Ponzone R, Simonetti G, Torricelli P, Valeri G (2008) Indications for breast magnetic resonance imaging. Consensus document “Attualità in senologia”, Florence 2007. Radiol Med 113(8):1085–1095CrossRefPubMed
17.
Zurück zum Zitat Kuhl CK, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, Schild HH (1999) Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 211(1):101–110CrossRefPubMed Kuhl CK, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, Schild HH (1999) Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 211(1):101–110CrossRefPubMed
18.
Zurück zum Zitat Moskowitz CS, Pepe MS (2006) Comparing the predictive values of diagnostic tests: sample size and analysis for paired study designs. Clin Trials 3(3):272–279CrossRefPubMed Moskowitz CS, Pepe MS (2006) Comparing the predictive values of diagnostic tests: sample size and analysis for paired study designs. Clin Trials 3(3):272–279CrossRefPubMed
19.
Zurück zum Zitat Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174CrossRefPubMed Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174CrossRefPubMed
22.
Zurück zum Zitat Mango VL, Morris EA, David Dershaw D, Abramson A, Fry C, Moskowitz CS, Hughes M, Kaplan J, Jochelson MS (2015) Abbreviated protocol for breast MRI: are multiple sequences needed for cancer detection? Eur J Radiol 84(1):65–70CrossRefPubMed Mango VL, Morris EA, David Dershaw D, Abramson A, Fry C, Moskowitz CS, Hughes M, Kaplan J, Jochelson MS (2015) Abbreviated protocol for breast MRI: are multiple sequences needed for cancer detection? Eur J Radiol 84(1):65–70CrossRefPubMed
23.
Zurück zum Zitat Grimm LJ, Soo MS, Yoon S, Kim C, Ghate SV, Johnson KS (2015) Abbreviated screening protocol for breast MRI: a feasibility study. Acad Radiol 22(9):1157–1162CrossRefPubMed Grimm LJ, Soo MS, Yoon S, Kim C, Ghate SV, Johnson KS (2015) Abbreviated screening protocol for breast MRI: a feasibility study. Acad Radiol 22(9):1157–1162CrossRefPubMed
24.
Zurück zum Zitat Harvey SC, Di Carlo PA, Lee B, Obadina E, Sippo D, Mullen L (2016) An abbreviated protocol for high-risk screening breast MRI saves time and resources. J Am Coll Radiol 13(11S):R74–R80CrossRefPubMed Harvey SC, Di Carlo PA, Lee B, Obadina E, Sippo D, Mullen L (2016) An abbreviated protocol for high-risk screening breast MRI saves time and resources. J Am Coll Radiol 13(11S):R74–R80CrossRefPubMed
25.
Zurück zum Zitat Jain M, Jain A, Hyzy MD, Werth G (2017) FAST MRI breast screening revisited. J Med Imaging Radiat Oncol 61(1):24–28CrossRefPubMed Jain M, Jain A, Hyzy MD, Werth G (2017) FAST MRI breast screening revisited. J Med Imaging Radiat Oncol 61(1):24–28CrossRefPubMed
26.
Zurück zum Zitat Moschetta M, Telegrafo M, Rella L, Stabile Ianora AA, Angelelli G (2016) Abbreviated combined MR protocol: a new faster strategy for characterizing breast lesions. Clin Breast Cancer 16(3):207–211CrossRefPubMed Moschetta M, Telegrafo M, Rella L, Stabile Ianora AA, Angelelli G (2016) Abbreviated combined MR protocol: a new faster strategy for characterizing breast lesions. Clin Breast Cancer 16(3):207–211CrossRefPubMed
Metadaten
Titel
Abbreviated breast dynamic contrast-enhanced MR imaging for lesion detection and characterization: the experience of an Italian oncologic center
verfasst von
Antonella Petrillo
Roberta Fusco
Mario Sansone
Marilena Cerbone
Salvatore Filice
Annamaria Porto
Maria Rosaria Rubulotta
Massimiliano D’Aiuto
Franca Avino
Maurizio Di Bonito
Gerardo Botti
Publikationsdatum
26.04.2017
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2017
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-017-4264-y

Weitere Artikel der Ausgabe 2/2017

Breast Cancer Research and Treatment 2/2017 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.